ERBB2 and gastric cancer: Nonetheless, the prognostic value of HER2 for GC is still a matter of controversy since the survival rates of GC patients with HER2 overexpression are subject to the influence of various factors, and the mechanisms of resistance to HER2-targeted therapy are still being studied [27,42,49,50].